World's Best Scientists 2026 revealed!
Award Badge
Medicine
Taiwan
2026

D-Index & Metrics

Medicine

D-Index
127
Citations
65369
World Ranking
2813
National Ranking
6

Pei-Jer Chen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pei-Jer Chen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 838 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pei-Jer Chen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pei-Jer Chen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 127 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Taiwan Leader Award
  • 2025 - Research.com Medicine in Taiwan Leader Award
  • 2023 - Research.com Medicine in Taiwan Leader Award
  • 2022 - Research.com Medicine in Taiwan Leader Award
  • 2011 - Fellow, The World Academy of Sciences

Overview

Pei-Jer Chen is affiliated with National Taiwan University in Taiwan and has contributed extensively to the field of medicine, with a particular focus on epidemiology, hepatology, molecular biology, infectious diseases, and oncology. Their research spans a wide range of topics including hepatitis B virus studies, hepatitis C virus research, liver disease diagnosis and treatment, hepatocellular carcinoma treatment and prognosis, SARS-CoV-2 and COVID-19 research, renal diseases and glomerulopathies, and hepatitis viruses studies and epidemiology.

Frequent coauthors in Pei-Jer Chen's work include Chun-Jen Liu, Jia-Horng Kao, Tung-Hung Su, Chen-Hua Liu, and Tai-Chung Tseng. This network indicates an active collaboration within the scientific community, particularly in areas related to viral hepatitis and liver diseases.

Publications by Pei-Jer Chen have appeared predominantly in the following venues:

  • Journal of the Formosan Medical Association
  • Journal of Hepatology
  • PubMed
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Hepatology International

Key recent papers from Pei-Jer Chen include:

  • Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects (2020, Cell Reports)
  • The Origin and Underlying Driving Forces of the SARS-CoV-2 Outbreak (2020, Journal of Biomedical Science)
  • 2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (II) Special Populations (2020, Journal of the Formosan Medical Association)
  • Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing (2020, Molecular Therapy - Nucleic Acids)
  • 2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (I) General Population (2020, Journal of the Formosan Medical Association)

Pei-Jer Chen's research prominently addresses viral infections and associated liver conditions. Much of the work focuses on hepatitis B and C viruses, with implications for the diagnosis, treatment, and management of liver diseases including hepatocellular carcinoma. Their research on SARS-CoV-2 aligns with the global scientific efforts during the COVID-19 pandemic to understand viral mechanisms and develop therapeutic strategies.

In recognition of their scientific contributions, Pei-Jer Chen was named a Fellow of The World Academy of Sciences in 2011. Continued publication activity and collaboration reflect an ongoing involvement in advancing medical knowledge, especially within their primary institutional affiliation in Taiwan.

Best Publications

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

    S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas

  • Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

    Masao Omata;Ann Lii Cheng;Norihiro Kokudo;Masatoshi Kudo

  • Hepatitis B e antigen and the risk of hepatocellular carcinoma.

    Hwai I. Yang;Sheng Nan Lu;Yun Fan Liaw;San Lin You

  • Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

    Jia-Horng Kao;Pei-Jer Chen;Ming-Yang Lai;§ Ding-Shinn Chen‡

  • Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

    Masao Omata;Laurentius A. Lesmana;Ryosuke Tateishi;Pei Jer Chen

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men

    Ming-Whei Yu;Shiou-Hwei Yeh;Pei-Jer Chen;Yun-Fan Liaw

  • Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

    Hwai I. Yang;Shiou Hwei Yeh;Pei Jer Chen;Pei Jer Chen;Uchenna H. Iloeje

  • Hepatitis B genotypes and the response to interferon therapy.

    Jia-Horng Kao;Nan-Hui Wu;Pei-Jer Chen;Ming-Yang Lai

  • High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

    Tai–Chung Tseng;Tai–Chung Tseng;Chun–Jen Liu;Hung–Chih Yang;Tung–Hung Su

  • Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

    Jia–Horng Kao;Pei–Jer Chen;Ming–Yang Lai;Ding–Shinn Chen

  • Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

    Hwai I. Yang;Hwai I. Yang;Man Fung Yuen;Henry Lik Yuen Chan;Kwang Hyub Han

  • Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

    Chi–Ling Chen;Hwai–I. Yang;Wei–Shiung Yang;Chun–Jen Liu

  • Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

    Calin Cainap;Shukui Qin;Wen-Tsung Huang;Ik Joo Chung

  • The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

    A. Sibley;Kwang Hyub Han;A. Abourached;L. A. Lesmana

  • How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

    Deepak N. Amarapurkar;Estsuko Hashimoto;Laurentius M. Adrianto Lesmana;José D. Sollano

  • Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation

    Ming Tseh Lin;Barry Storer;Paul J. Martin;Paul J. Martin;Li Hui Tseng

  • The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

    Su-Ru Lin;Hung-Chih Yang;Yi-Ting Kuo;Chun-Jen Liu

  • The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus.

    Fu-Lin Chang;Pei-Jer Chen;Su-Jen Tu;Chuan-Jen Wang

  • Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

    S L Tsai;Pei-Jer Chen;M Y Lai;P M Yang

Frequent Co-Authors

Ding-Shinn Chen
Ding-Shinn Chen National Taiwan University
Jia-Horng Kao
Jia-Horng Kao National Taiwan University
Chun-Jen Liu
Chun-Jen Liu National Taiwan University
Ming-Yang Lai
Ming-Yang Lai National Taiwan University
Shiou-Hwei Yeh
Shiou-Hwei Yeh National Taiwan University
Hung-Chih Yang
Hung-Chih Yang National Taiwan University
Ann-Lii Cheng
Ann-Lii Cheng National Taiwan University
Chien-Jen Chen
Chien-Jen Chen Academia Sinica
Mei-Hwei Chang
Mei-Hwei Chang National Taiwan University
Hong-Yuan Hsu
Hong-Yuan Hsu National Taiwan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, it’s helpful to explore related healthcare degrees and alternative career pathways. Many students look for flexible options that allow them to start working in healthcare without spending years in medical school.

For those who want a nursing career, you might consider enrolling in the easiest bsn program to get into. These programs typically have more accessible admission requirements, making them a great choice for newcomers. Similarly, there are nursing schools that don't require teas test, saving you the need to prepare for additional entrance exams.

If you’re interested in administrative roles, consider earning an accelerated healthcare administration degree online. This can quickly prepare you for healthcare management and leadership positions.

Lastly, non-clinical careers, such as working in medical records, are also in demand. You can attend medical billing and coding schools online with financial aid to start a career in the fast-growing health information field.

Best Scientists Citing Pei-Jer Chen

Trending Scientists